Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2004 2
2005 6
2006 9
2007 7
2008 5
2009 3
2010 8
2011 7
2012 2
2013 11
2014 12
2015 14
2016 8
2017 20
2018 15
2019 11
2020 16
2021 18
2022 10
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. Conroy T, et al. Among authors: michel p. N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923. N Engl J Med. 2011. PMID: 21561347 Free article. Clinical Trial.
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
Conroy T, Galais MP, Raoul JL, Bouché O, Gourgou-Bourgade S, Douillard JY, Etienne PL, Boige V, Martel-Lafay I, Michel P, Llacer-Moscardo C, François E, Créhange G, Abdelghani MB, Juzyna B, Bedenne L, Adenis A; Fédération Francophone de Cancérologie Digestive and UNICANCER-GI Group. Conroy T, et al. Among authors: michel p. Lancet Oncol. 2014 Mar;15(3):305-14. doi: 10.1016/S1470-2045(14)70028-2. Epub 2014 Feb 18. Lancet Oncol. 2014. PMID: 24556041 Clinical Trial.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 Feb 19:S0923-7534(24)00049-8. doi: 10.1016/j.annonc.2024.02.005. Online ahead of print. Ann Oncol. 2024. PMID: 38382875 Free article.
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C; LAP07 Trial Group. Hammel P, et al. JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324. JAMA. 2016. PMID: 27139057 Clinical Trial.
Metastatic colorectal cancer.
Bouche O, Conroy T, Michel P, Penna C, Tournigand C. Bouche O, et al. Among authors: michel p. Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S30-2S42. Gastroenterol Clin Biol. 2006. PMID: 17151561 Free article. Review. No abstract available.
[Aspirin and colorectal cancer].
Grancher A, Michel P, Di Fiore F, Sefrioui D. Grancher A, et al. Among authors: michel p. Bull Cancer. 2018 Feb;105(2):171-180. doi: 10.1016/j.bulcan.2017.09.013. Epub 2017 Nov 15. Bull Cancer. 2018. PMID: 29153543 Review. French.
[Olaparib and pancreatic cancer: A challenging Lesson].
Louvet C, Samalin E, Michel P. Louvet C, et al. Among authors: michel p. Bull Cancer. 2019 Sep;106(9):715-716. doi: 10.1016/j.bulcan.2019.07.002. Epub 2019 Aug 6. Bull Cancer. 2019. PMID: 31399206 French. No abstract available.
Cancer of the stomach.
Pezet D, Michel P, Rebischung C, Ychou M. Pezet D, et al. Among authors: michel p. Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S16-2S23. Gastroenterol Clin Biol. 2006. PMID: 17151559 Free article. Review. No abstract available.
Colorectal cancer chemoprevention: is aspirin still in the game?
Grancher A, Michel P, Di Fiore F, Sefrioui D. Grancher A, et al. Among authors: michel p. Cancer Biol Ther. 2022 Dec 31;23(1):446-461. doi: 10.1080/15384047.2022.2104561. Cancer Biol Ther. 2022. PMID: 35905195 Free PMC article. Review.
169 results